Weinfurt, Kevin P.
Bollinger, Juli M.
May, Elizabeth
Geller, Gail
Mathews, Debra J. H.
Morain, Stephanie R.
Schmid, Lorrie
Bloom, Diane L.
Sugarman, Jeremy
Funding for this research was provided by:
NIH Office of the Director (U24AT009676)
Article History
Received: 16 February 2021
Accepted: 28 July 2021
First Online: 12 August 2021
Declarations
:
: Dr. Sugarman is a member of Merck KGaA’s Bioethics Advisory Panel and Stem Cell Research Oversight Committee; a member of IQVIA’s Ethics Advisory Panel; a member of Aspen Neurosciences’ Scientific Advisory Board; a consultant for Biogen; and a consultant for Portola Pharmaceuticals, Inc. None of these activities is related to the material discussed in this manuscript. No other authors reported conflicts of interest.
: The views presented here are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health.
Free to read: This content has been made available to all.